-
1
-
-
21244503047
-
Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin
-
Barthomeuf C., Grassi J., Demeule M., Fournier C., Boivin D., Béliveau R. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin. Cancer Chemother. Pharmacol. 2005, 56:173-181.
-
(2005)
Cancer Chemother. Pharmacol.
, vol.56
, pp. 173-181
-
-
Barthomeuf, C.1
Grassi, J.2
Demeule, M.3
Fournier, C.4
Boivin, D.5
Béliveau, R.6
-
2
-
-
0018386220
-
Avermectins, new family of potent anthelmintic agents: producing organism and fermentation
-
Burg R.W., Miller B.M., Baker E.E., Birnbaum J., Currie S.A., Hartman R., Kong Y.L., Monaghan R.L., Olson G., Putter I., Tunac J.B., Wallick H., Stapley E.O., Oiwa R., Omura S. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob. Agents Chemother. 1979, 15:361-367.
-
(1979)
Antimicrob. Agents Chemother.
, vol.15
, pp. 361-367
-
-
Burg, R.W.1
Miller, B.M.2
Baker, E.E.3
Birnbaum, J.4
Currie, S.A.5
Hartman, R.6
Kong, Y.L.7
Monaghan, R.L.8
Olson, G.9
Putter, I.10
Tunac, J.B.11
Wallick, H.12
Stapley, E.O.13
Oiwa, R.14
Omura, S.15
-
3
-
-
4344563023
-
Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318
-
Chen L.M., Liang Y.J., Ruan J.W., Ding Y., Wang X.W., Shi Z., Gu L.Q., Yang X.P., Fu L.W. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. J. Pharm. Pharmacol. 2004, 56:1061-1066.
-
(2004)
J. Pharm. Pharmacol.
, vol.56
, pp. 1061-1066
-
-
Chen, L.M.1
Liang, Y.J.2
Ruan, J.W.3
Ding, Y.4
Wang, X.W.5
Shi, Z.6
Gu, L.Q.7
Yang, X.P.8
Fu, L.W.9
-
4
-
-
33745831231
-
Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters
-
Choudhuri S., Klaassen C.D. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol. 2006, 25:231-259.
-
(2006)
Int. J. Toxicol.
, vol.25
, pp. 231-259
-
-
Choudhuri, S.1
Klaassen, C.D.2
-
5
-
-
0029966747
-
The abamectin derivative ivermectin is potent Pglycoprotein inhibitor
-
Dider A., Loor F. The abamectin derivative ivermectin is potent Pglycoprotein inhibitor. Anticancer Drugs 1996, 7:745-751.
-
(1996)
Anticancer Drugs
, vol.7
, pp. 745-751
-
-
Dider, A.1
Loor, F.2
-
6
-
-
51849149141
-
Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae
-
Huang M., Jin J., Sun H., Liu G.T. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Cancer Chemother. Pharmacol. 2008, 62:1015-1026.
-
(2008)
Cancer Chemother. Pharmacol.
, vol.62
, pp. 1015-1026
-
-
Huang, M.1
Jin, J.2
Sun, H.3
Liu, G.T.4
-
7
-
-
33847219338
-
Di(2-ethylhexyl)phthalate leached from medical PVC devices serves as a substrate and inhibitor for the P-glycoprotein
-
Kim J.H., Yun J., Sohng J.K., Cha J.M., Choi B.C., Jeon H.J., Kim S.H., Choi C.H. Di(2-ethylhexyl)phthalate leached from medical PVC devices serves as a substrate and inhibitor for the P-glycoprotein. Environ. Toxicol. Pharmacol. 2007, 23:272-278.
-
(2007)
Environ. Toxicol. Pharmacol.
, vol.23
, pp. 272-278
-
-
Kim, J.H.1
Yun, J.2
Sohng, J.K.3
Cha, J.M.4
Choi, B.C.5
Jeon, H.J.6
Kim, S.H.7
Choi, C.H.8
-
8
-
-
34447301503
-
Inhibition of P-glycoprotein function by tannic acid and pentagalloylglucose
-
Kitagawa S., Nabekura T., Nakamura Y., Takahashi T., Kashiwada Y. Inhibition of P-glycoprotein function by tannic acid and pentagalloylglucose. J. Pharm. Pharmacol. 2007, 59:965-969.
-
(2007)
J. Pharm. Pharmacol.
, vol.59
, pp. 965-969
-
-
Kitagawa, S.1
Nabekura, T.2
Nakamura, Y.3
Takahashi, T.4
Kashiwada, Y.5
-
9
-
-
41949141389
-
Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line
-
Klamt F., Passos D.T., Castro M.A., Gelain D.P., Grivicich I., Moreira J.C. Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line. Toxicol. in Vitro 2008, 22:873-878.
-
(2008)
Toxicol. in Vitro
, vol.22
, pp. 873-878
-
-
Klamt, F.1
Passos, D.T.2
Castro, M.A.3
Gelain, D.P.4
Grivicich, I.5
Moreira, J.C.6
-
10
-
-
2942579691
-
Avermectins inhibit multidrug resistance of tumor cells
-
Korystov Y.N., Ermakova N.V., Kublik L.N., Levitman M.Kh., Shaposhnikova V.V., Mosin V.A., Drinyaev V.A., Kruglyak E.B., Novik T.S., Sterlina T.S. Avermectins inhibit multidrug resistance of tumor cells. Eur. J. Pharmacol. 2004, 493:57-64.
-
(2004)
Eur. J. Pharmacol.
, vol.493
, pp. 57-64
-
-
Korystov, Y.N.1
Ermakova, N.V.2
Kublik, L.N.3
Levitman, M.4
Shaposhnikova, V.V.5
Mosin, V.A.6
Drinyaev, V.A.7
Kruglyak, E.B.8
Novik, T.S.9
Sterlina, T.S.10
-
11
-
-
0033799839
-
Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs
-
Krishna R., Mayer L.D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 2000, 11:265-283.
-
(2000)
Eur. J. Pharm. Sci.
, vol.11
, pp. 265-283
-
-
Krishna, R.1
Mayer, L.D.2
-
12
-
-
17544368685
-
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
-
Leslie E.M., Deeley R.G., Cole S.P. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 2005, 204:216-237.
-
(2005)
Toxicol. Appl. Pharmacol.
, vol.204
, pp. 216-237
-
-
Leslie, E.M.1
Deeley, R.G.2
Cole, S.P.3
-
13
-
-
30944466044
-
Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)
-
Lespine A., Dupuy J., Orlowski S., Nagy T., Glavinas H., Krajcsi P., Alvinerie M. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem.-Biol. Interact. 2006, 159:169-179.
-
(2006)
Chem.-Biol. Interact.
, vol.159
, pp. 169-179
-
-
Lespine, A.1
Dupuy, J.2
Orlowski, S.3
Nagy, T.4
Glavinas, H.5
Krajcsi, P.6
Alvinerie, M.7
-
14
-
-
33845463597
-
Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship
-
Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 2007, 30:84-94.
-
(2007)
Eur. J. Pharm. Sci.
, vol.30
, pp. 84-94
-
-
Lespine, A.1
Martin, S.2
Dupuy, J.3
Roulet, A.4
Pineau, T.5
Orlowski, S.6
Alvinerie, M.7
-
15
-
-
0034945212
-
Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line
-
Li J., Xu L.Z., He K.L., Guo W.J., Zheng Y.H., Xia P., Chen Y. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Breast Cancer Res. 2001, 3:253-263.
-
(2001)
Breast Cancer Res.
, vol.3
, pp. 253-263
-
-
Li, J.1
Xu, L.Z.2
He, K.L.3
Guo, W.J.4
Zheng, Y.H.5
Xia, P.6
Chen, Y.7
-
16
-
-
58149185271
-
Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells
-
Li X., Sun B., Zhu C.J., Yuan H.Q., Shi Y.Q., Gao J., Li S.J., Lou H.X. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells. Toxicol. in Vitro 2009, 23:29-36.
-
(2009)
Toxicol. in Vitro
, vol.23
, pp. 29-36
-
-
Li, X.1
Sun, B.2
Zhu, C.J.3
Yuan, H.Q.4
Shi, Y.Q.5
Gao, J.6
Li, S.J.7
Lou, H.X.8
-
17
-
-
11144323815
-
Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract
-
Limtrakul P., Khantamat O., Pintha K. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Cancer Chemother. Pharmacol. 2004, 54:525-530.
-
(2004)
Cancer Chemother. Pharmacol.
, vol.54
, pp. 525-530
-
-
Limtrakul, P.1
Khantamat, O.2
Pintha, K.3
-
18
-
-
73649120349
-
Multidrug resistance associated proteins and implications in drug development
-
Liu Y.H., Di Y.M., Zhou Z.W., Mo S.L., Zhou S.F. Multidrug resistance associated proteins and implications in drug development. Clin. Exp. Pharmacol. Physiol. 2010, 37:115-120.
-
(2010)
Clin. Exp. Pharmacol. Physiol.
, vol.37
, pp. 115-120
-
-
Liu, Y.H.1
Di, Y.M.2
Zhou, Z.W.3
Mo, S.L.4
Zhou, S.F.5
-
19
-
-
0033568540
-
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line
-
Maliepaard M., van Gastelen M.A., de Jong L.A., Pluim D., van Waardenburg R.C., Ruevekamp-Helmers M.C., Floot B.G., Schellens J.H. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 1999, 59:4559-4563.
-
(1999)
Cancer Res.
, vol.59
, pp. 4559-4563
-
-
Maliepaard, M.1
van Gastelen, M.A.2
de Jong, L.A.3
Pluim, D.4
van Waardenburg, R.C.5
Ruevekamp-Helmers, M.C.6
Floot, B.G.7
Schellens, J.H.8
-
21
-
-
72549111454
-
Eosinophilic folliculitis with a Demodex folliculorum infestation successfully treated with ivermectin in a man infected with human immunodeficiency virus
-
Nara T., Katoh N., Inoue K., Yamada M., Arizono N., Kishimoto S. Eosinophilic folliculitis with a Demodex folliculorum infestation successfully treated with ivermectin in a man infected with human immunodeficiency virus. Clin. Exp. Dermatol. 2009, 34:e981-983.
-
(2009)
Clin. Exp. Dermatol.
, vol.34
-
-
Nara, T.1
Katoh, N.2
Inoue, K.3
Yamada, M.4
Arizono, N.5
Kishimoto, S.6
-
22
-
-
33747352798
-
MDR- and CYP3A4-mediated drug-drug interactions
-
Pal D., Mitra A.K. MDR- and CYP3A4-mediated drug-drug interactions. J. Neuroimmune Pharmacol. 2006, 1:323-339.
-
(2006)
J. Neuroimmune Pharmacol.
, vol.1
, pp. 323-339
-
-
Pal, D.1
Mitra, A.K.2
-
23
-
-
67349092076
-
In vitro and in vivo interaction of moxidectin with BCRP/ABCG2
-
Perez M., Blazquez A.G., Real R., Mendoza G., Prieto J.G., Merino G., Alvarez A.I. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2. Chem.-Biol. Interact. 2009, 180:106-112.
-
(2009)
Chem.-Biol. Interact.
, vol.180
, pp. 106-112
-
-
Perez, M.1
Blazquez, A.G.2
Real, R.3
Mendoza, G.4
Prieto, J.G.5
Merino, G.6
Alvarez, A.I.7
-
24
-
-
26844497219
-
Changes in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroids
-
Ponce de León V., Barrera-Rodríguez R. Changes in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroids. Cancer Cell Int. 2005, 5:20.
-
(2005)
Cancer Cell Int.
, vol.5
, pp. 20
-
-
Ponce de León, V.1
Barrera-Rodríguez, R.2
-
25
-
-
0031060625
-
Reversal of P-glycoprotein-associated multidrug resistance by ivermectin
-
Pouliot J.F., L'Heureux F., Liu Z., Prichard R.K., Georges E. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. 1997, 53:17-25.
-
(1997)
Biochem. Pharmacol.
, vol.53
, pp. 17-25
-
-
Pouliot, J.F.1
L'Heureux, F.2
Liu, Z.3
Prichard, R.K.4
Georges, E.5
-
26
-
-
26044454086
-
Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?
-
Prichard R.K. Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?. Vet. Parasitol. 2005, 133:243-253.
-
(2005)
Vet. Parasitol.
, vol.133
, pp. 243-253
-
-
Prichard, R.K.1
-
27
-
-
49349114710
-
Reversal effect of tyroservatide (YSV) tripeptide on multi-resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU
-
Shi L.X., Ma R., Lu R., Xu Q., Zhu Z.F., Wang L., Zhou C.L., Li X.L., Zhang H.L., Yao Z. Reversal effect of tyroservatide (YSV) tripeptide on multi-resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. Cancer Lett. 2008, 269:101-110.
-
(2008)
Cancer Lett.
, vol.269
, pp. 101-110
-
-
Shi, L.X.1
Ma, R.2
Lu, R.3
Xu, Q.4
Zhu, Z.F.5
Wang, L.6
Zhou, C.L.7
Li, X.L.8
Zhang, H.L.9
Yao, Z.10
-
28
-
-
41149176382
-
Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells
-
Shi Y.Q., Qu X.J., Liao Y.X., Xie C.F., Cheng Y.N., Li S., Lou H.X. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Eur. J. Pharmacol. 2008, 584:66-71.
-
(2008)
Eur. J. Pharmacol.
, vol.584
, pp. 66-71
-
-
Shi, Y.Q.1
Qu, X.J.2
Liao, Y.X.3
Xie, C.F.4
Cheng, Y.N.5
Li, S.6
Lou, H.X.7
-
29
-
-
0030738096
-
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
-
Sikic B.I., Fisher G.A., Lum B.L., Halsey J., Beketic-Oreskovic L., Chen G. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother. Pharmacol. 1997, 40:S13-S19.
-
(1997)
Cancer Chemother. Pharmacol.
, vol.40
-
-
Sikic, B.I.1
Fisher, G.A.2
Lum, B.L.3
Halsey, J.4
Beketic-Oreskovic, L.5
Chen, G.6
-
30
-
-
0034102806
-
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma
-
Theis J.G., Chan H.S., Greenberg M.L., Malkin D., Karaskov V., Moncica I., Koren G., Doyle J. Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma. Med. Pediatr. Oncol. 2000, 34:242-249.
-
(2000)
Med. Pediatr. Oncol.
, vol.34
, pp. 242-249
-
-
Theis, J.G.1
Chan, H.S.2
Greenberg, M.L.3
Malkin, D.4
Karaskov, V.5
Moncica, I.6
Koren, G.7
Doyle, J.8
-
31
-
-
0037358040
-
Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein
-
Thomas H., Coley H.M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control 2003, 10:159-165.
-
(2003)
Cancer Control
, vol.10
, pp. 159-165
-
-
Thomas, H.1
Coley, H.M.2
-
32
-
-
0036615555
-
Synthesis of milbemycins b 9 and b 10 from milbemycins A3 and A4 and their biological activities
-
Tsukiyama T., Kinoshita A., Ichinose R., Sato K. Synthesis of milbemycins b 9 and b 10 from milbemycins A3 and A4 and their biological activities. Biosci. Biotechnol. Biochem. 2002, 66:1407-1411.
-
(2002)
Biosci. Biotechnol. Biochem.
, vol.66
, pp. 1407-1411
-
-
Tsukiyama, T.1
Kinoshita, A.2
Ichinose, R.3
Sato, K.4
-
33
-
-
4444360558
-
Synthesis of novel 26-substituted milbemycin A4 derivatives and their acaricidal activities
-
Tsukiyama T., Kajino H., Tsukamoto Y., Nakagawa H., Yanai T., Sato K., Yokoi S., Ichinose R., Tanaka K. Synthesis of novel 26-substituted milbemycin A4 derivatives and their acaricidal activities. J. Antibiot. 2004, 57:446-455.
-
(2004)
J. Antibiot.
, vol.57
, pp. 446-455
-
-
Tsukiyama, T.1
Kajino, H.2
Tsukamoto, Y.3
Nakagawa, H.4
Yanai, T.5
Sato, K.6
Yokoi, S.7
Ichinose, R.8
Tanaka, K.9
-
34
-
-
0019430432
-
Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
-
Tsuruo T., Ikda H., Tsukayoshi S., Sajurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981, 41:1967-1972.
-
(1981)
Cancer Res.
, vol.41
, pp. 1967-1972
-
-
Tsuruo, T.1
Ikda, H.2
Tsukayoshi, S.3
Sajurai, Y.4
-
35
-
-
40549125358
-
Natural and synthetic polymers as inhibitors of drug efflux pumps
-
Werle M. Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm. Res. 2008, 25:500-511.
-
(2008)
Pharm. Res.
, vol.25
, pp. 500-511
-
-
Werle, M.1
-
36
-
-
67650656774
-
Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies
-
Wu C.P., Calcagno A.M., Ambudkar S.V. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr. Mol. Pharmacol. 2008, 1:93-105.
-
(2008)
Curr. Mol. Pharmacol.
, vol.1
, pp. 93-105
-
-
Wu, C.P.1
Calcagno, A.M.2
Ambudkar, S.V.3
-
37
-
-
60649096849
-
Cepharanthine is a potent reversal agent for MRP7 (ABCC10)-mediated multidrug resistance
-
Zhou Y., Hopper-Borge E., Shen T., Huang X.C., Shi Z., Kuang Y.H., Furukawa T., Akiyama S., Peng X.X., Ashby C.R., Chen X., Kruh G.D., Chen Z.S. Cepharanthine is a potent reversal agent for MRP7 (ABCC10)-mediated multidrug resistance. Biochem. Pharmacol. 2009, 77:993-1001.
-
(2009)
Biochem. Pharmacol.
, vol.77
, pp. 993-1001
-
-
Zhou, Y.1
Hopper-Borge, E.2
Shen, T.3
Huang, X.C.4
Shi, Z.5
Kuang, Y.H.6
Furukawa, T.7
Akiyama, S.8
Peng, X.X.9
Ashby, C.R.10
Chen, X.11
Kruh, G.D.12
Chen, Z.S.13
|